Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.4950
At close: Mar 26, 5:00 PM EST
$0.3501
-0.14-29.27%
After Hours: Mar 16, 7:52 PM EST
LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. Analyst Ratings
LYRAOTCPK
LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. Analyst Ratings and Price Targets | OTC:LYRA | Benzinga
LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. has a consensus price target of $9.17 based on the ratings of 5 analysts. The high is $16 issued by HC Wainwright & Co. on August 14, 2025. The low is $0.5 issued by Jefferies on May 7, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on August 14, 2025, June 10, 2025, and March 14, 2025, respectively. With an average price target of $11.33 between HC Wainwright & Co., there's an implied 3137.17% upside for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Jefferies
B of A Securities
1calculated from analyst ratings
Analyst Ratings for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc.
Loading calendar...
FAQ
What is the target price for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) stock?
The latest price target for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (OTCPK:LYRA) was reported by HC Wainwright & Co. on August 14, 2025. The analyst firm set a price target for $16.00 expecting LYRA to rise to within 12 months (a possible 4470.12% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA)?
The latest analyst rating for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (OTCPK:LYRA) was provided by HC Wainwright & Co., and LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. reiterated their neutral rating.
When was the last upgrade for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA)?
There is no last upgrade for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc.
When was the last downgrade for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA)?
The last downgrade for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. happened on May 7, 2024 when HC Wainwright & Co. changed their price target from N/A to $2 for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc..
When is the next analyst rating going to be posted or updated for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc., and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. was filed on August 14, 2025 so you should expect the next rating to be made available sometime around August 14, 2026.
Is the Analyst Rating LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) correct?
While ratings are subjective and will change, the latest LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) rating was a reiterated with a price target of $16.00 to $16.00. The current price LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) is trading at is $0.35, which is out of the analyst’s predicted range.
